SlideShare a Scribd company logo
A flexible, affordable and fast R&D outsourcing service
partner
Company overview

    BLIRT (BioLab Innovative Research Technologies) is a private biotechnology
    company founded in 2008 with head office based in Gdansk, Poland.

    BLIRT has a unique hybrid model, an innovative biopharmaceutical service
    provider with Contract Research Organization. BLIRT offers a suite of biology
    and chemistry services, attractive especially for discovery and lead optimization
    development phase.

     BLIRT has modern laboratories and competent staff with a high percentage
    of internationally educated PhDs.

    We are able to accommodate small and bigger projects, and can engage
    project resources on long term contract or as-needed basis.


                       www.blirt.eu
                                                                                        2
Research Team

          891 publications in the field of life science

         ( Medicine, Microbiology, Molecular
         Biology, Biotechnology, Biochemistry, Organic Chemistry, Analytical
         Chemistry, Molecular Modeling)



    BLIRT employes 34 people after 2 years activity.

    The Research Team consists of 22 researchers where 9 are PhDs at
    molecular biology, biotechnology, organic chemistry and computer
    chemistry.



                     www.blirt.eu
                                                                               3
Our machinery




         www.blirt.eu
                        4
Protein Department
    We offer a broad spectrum of custom services from gene to protein helping
    you to speed up your development and to increase the efficiency.


          Gene                     Production                      Purification                  Protein

In silico gene synthesis        Proof of concept
                                                              Downstream Processing Formulation Adjustment
    Metagenomics               Difficult to express               Optimization
                               proteins solutions                                         Analytical testing
         PCR                                                 Chromatography methods
                                E.coli, P.pastoris,          development and validation
DNA and cDNA library       B. megaterium, S.cerevisiae
   construction                                               Unique resin synthesis
                           Flask and Bioreactor (10L)          for special proteins
  Gene engineering          expression optimizations

                                              www.blirt.eu
Protein Department

   Choosing the right expression strain of E.coli

                                                           Expression T7 system: OD600=0,3, IPTG to
   1    2   3   4   5   6   M   7   8   9   10   11   12        1mM, 30oC, 6h, TB broth.

                                                           1.     E.coli strain 1 protein I (whole fraction)
                                                           2.     E.coli strain 1 protein I (soluble fraction)
                                                           3.     E.coli strain 2 protein I (whole fraction)
                                                           4.     E.coli strain 2 protein I (soluble fraction)
                                                           5.     E.coli strain 3 protein I (whole fraction)
                                                           6.     E.coli strain 3 protein I (soluble fraction)
                                                           M.    Protein weight marker
                                                                 (170, 130, 100, 70, 55, 40, 35, 25, 15, 10 kDa)
                                                           7.     E.coli strain 4 protein I (whole fraction)
                                                           8.     E.coli strain 4 protein I (soluble fraction)
                                                           9.     E.coli strain 5 protein I (whole fraction)
                                                           10.    E.coli strain 5 protein I (soluble fraction)
                                                           11.    E.coli strain 6 protein I (whole fraction)
                                                           12.    E.coli strain 6 protein I (soluble fraction)




                                www.blirt.eu                                                                       6
Protein Department

                          Screening for expression temperature                                                     Purification
                                                                                                          M       1       2     3    4
                            M       1       2     3    4      5
                                                                                                          5
                            6




Expression T7 system: OD600=0,3, IPTG to 1mM, various oC, 6 h, TB broth.            Expression T7 system: OD600=0,3, IPTG to 1mM, 37 oC, 6 h, TB broth.

M.     Protein weight marker (170, 130, 100, 70, 55, 40, 35, 25, 15, 10 kDa)        M.     Protein weight marker (130, 90, 66, 40, 25, 10 kDa)
1.     18oC E.coli strain 1 protein II (whole fraction)                             1.     E.coli strain 2 protein III (soluble fraction)
2.     18oC E.coli strain 1 protein II (soluble fraction)                           2.     E.coli strain 2 protein III DEAE Sepharose week anion exchanger
3.     30oC E.coli strain 1 protein II (whole fraction)                             3.     E.coli strain 2 protein III Mono Q strong anion exchanger
4.     30oC E.coli strain 1 protein II (soluble fraction)                           4.     E.coli strain 2 protein III Octyl Sepharose HIC
5.     37oC E.coli strain 1 protein II (whole fraction)                             5.     Formulated protein III
6.     37oC E.coli strain 1 protein II (soluble fraction)

                                                                     www.blirt.eu
                                                                                                                                                             7
Protein Department
1   2   M   4   5   6   7   8   9   10   11   12 13 14   15   Intracellular production of a therapeutic protein by E.coli.
                                                              Soluble protein

                                                              Loading buffer at various pH.
                                                              Elution stepwise with 50mM Hepes
                                                              1M NaCl pH=7,0                             DEAE Sepharose
                                                                                                         1.  pH=4,5
                                                                                                         2.  pH=5,5
                                                                                                         M.  Protein weight marker
                                                                                                             (170, 130, 100, 70, 55, 40, 35, 25, 15, 10
                                                                                                             kDa)
                                                                                                         4.   pH=6,5
                                                              Loading buffer containing Triton X-        5.   pH=7,5
                                                              100 (R) as additive at various pH.         6.   pH=8,5
                                                              Elution stepwise with 50mM Hepes           7.   pH=9,5
                                                              1M NaCl pH=7,0                             8.   pH=10,5
                                                                                                         CM Sepharose
                                                                                                         9.   pH=4,5
                                                                                                         10.  pH=5,5
                                                                                                         11.  pH=6,5
                                                              Loading buffer containing L-               12.  pH=7,5
                                                              Arginine as additive at various pH.        13.  pH=8,5
                                                              Elution stepwise with 50mM Hepes           14.  pH=9,5
                                                              1M NaCl pH=7,0                             15.  pH=10,5


                                                                          www.blirt.eu
                                                                                                                                                          8
Analysis department
BLIRT specializes in development of new methods and analyses that are not
possible in diagnostics laboratories. We are also able to conduct all routine
tests, particularly those that require our unique equipment.

Example analyses that we are able to perform:

• Analysis of drugs and its metabolites concentration in blood, urine, other biological fluids and
tissues,
• Pharmacokinetic analysis after drug administration,
• ADME studies – complex analysis of absorption, distribution, metabolism and excretion,
• Analysis of purity, stability and protein binding of pharmaceuticals,
• Analysis of biochemical markers in blood, urine, other biological fluids and tissues,
• Determination of molecular weight and purity of proteins and peptides,
• Protein and peptide sequencing following partial proteolysis.

                                        www.blirt.eu
                                                                                                     9
Analysis department
BLIRT can provide you access to most advanced analytical equipment and high
profile scientists with many years of experience in biomedical analytics.

Overview of Analytical Methods:
Ultra-High Performance Lipid Chromatography with mass detection (UHPLC-MS/MS) connected to newest
generation of quadrupole time of flight mass detector (Q-TOF) with source of ions type electro-spray (ESI) or
chemical ionization under atmospheric pressure (APCI).
High Performance Lipid Chromatography (HPLC) with detection: RID, FL and UV-DAD.
Infrared spectroscopy with Fourier Transformation (IR).
Spectroscopy UV-VIS.
                                                                        Detectors:
Overview of Analytical Equipment:                                       micrOTOF-Q-II - Bruker
Spectrometer UV-VIS – Jasco                                             RID – Shodex
Spectrometer IR- Jasco                                                  FL-Merck
HPLC-Merck                                                              UV-DAD - Dionex
UHPLC-Dionex                                                            FID- Perkin Elmer
PLC- Dionex                                                             ECD-Perkin Elmer
GC-Perkin- Elmer                                                        NPD- Perkin Elmer MS/MS - Bruker
                                                                                                           10
Synthesis department
              BLIRT – Synthesis services
    We offer all-embracing organic synthesis services directed to industrial and
    scientific customers:
           Pharmaceutical Industry;
           Chemical Industry;
           Academic Scientists;

    In particular we specialize in synthesis:
     chiral compounds with natural origin – with synthetic and bio-catalytic
    methods;
     chiral unnatural/non-peptidic amino acids;
     peptides (‘on solid state’ and ‘in solution’);
     heterocyclic compounds (with N, O, S in ring structure);
     macrocyclic compounds;
     phosphoroorganic compounds;



                       www.blirt.eu
                                                                                   11
Synthesis department
We offer comprehensive organic synthesis and interdisciplinary chemistry
services:
       Custom synthesis - comprehensive equiped laboratory: mg – 100s g scale;
       Design of alternative synthetic pathways;
       Optimalization of synthetic routes;
       Reaction yields optimalization;
       Identification, synthesis and standarization of API impurities;
       Identification, synthesis and standarization of drug metabolites;
                            COOMe                    O                              OH
                   CHO                 A                        B
                                                          CH3                              CH3
                       Br
                                                     COOMe                          COOMe
                   F          CH3                F                          F


                                                                                C

                                                                                    OH
                                 CH3   E                        D                          CH3
                                                       CH3
                       O    CN                       COOH
                                                O                                   COOH
                                                                            F

                                           www.blirt.eu
Collaboration models

     Fee for Service

     Co-development

     FTE

     Consulting

             www.blirt.eu
                            13
Summary
   Key benefits of collaboration
     • Competitive pricing
     • Short project deadlines
     • Strong scientific team
     • State of the art facilities


    Service Quality
      • ISO 9001:2009 - certificate
      • GLP - pending.- 03.2011
      • GMP – planned for 2013
                                      14

More Related Content

What's hot

Ricerca Early Safety Assays
Ricerca Early Safety AssaysRicerca Early Safety Assays
Ricerca Early Safety Assays
karenbernards
 
Sigma Xi - EKS95460- ekta sharma
Sigma Xi - EKS95460- ekta sharmaSigma Xi - EKS95460- ekta sharma
Sigma Xi - EKS95460- ekta sharma
erku2210
 
Expression of Genetically Engineered Chitinase Gene of Pyrococcus furiosus
Expression of Genetically Engineered Chitinase Gene of Pyrococcus furiosusExpression of Genetically Engineered Chitinase Gene of Pyrococcus furiosus
Expression of Genetically Engineered Chitinase Gene of Pyrococcus furiosus
IJERDJOURNAL
 
Overcoming Key Challenges of Protein Mass Spectrometry Sample Preparation
Overcoming Key Challenges of Protein Mass Spectrometry Sample PreparationOvercoming Key Challenges of Protein Mass Spectrometry Sample Preparation
Overcoming Key Challenges of Protein Mass Spectrometry Sample Preparation
Mourad FERHAT, PhD
 
Glass bead transformation method for gram positive bacteria
Glass bead transformation method for gram positive bacteriaGlass bead transformation method for gram positive bacteria
Glass bead transformation method for gram positive bacteria
CAS0609
 
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Ailen Ramos
 
Bio outsource vaccinetesting_europe
Bio outsource vaccinetesting_europeBio outsource vaccinetesting_europe
Bio outsource vaccinetesting_europe
Muhammad J. Sadiq
 
J. Ingram, D. Poulcharidis - Adv. Topics of Chem. Bio. - Dr. Webb - Prof. S. ...
J. Ingram, D. Poulcharidis - Adv. Topics of Chem. Bio. - Dr. Webb - Prof. S. ...J. Ingram, D. Poulcharidis - Adv. Topics of Chem. Bio. - Dr. Webb - Prof. S. ...
J. Ingram, D. Poulcharidis - Adv. Topics of Chem. Bio. - Dr. Webb - Prof. S. ...
JDIngram
 
Take part in research to combat atherosclerosis
Take part in research to combat atherosclerosisTake part in research to combat atherosclerosis
Take part in research to combat atherosclerosis
Xplore Health
 
Monoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionMonoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartion
shadan87
 
Pepsi bio link
Pepsi bio linkPepsi bio link
Pepsi bio link
bio-link
 
Bmm microbial enzymes
Bmm microbial enzymesBmm microbial enzymes
Bmm microbial enzymes
ShilanjaliBhalerao
 
Alexander Lazarev, Ph.D. presentation at ANALYTICA Biotech Forum
Alexander Lazarev, Ph.D.  presentation at ANALYTICA Biotech ForumAlexander Lazarev, Ph.D.  presentation at ANALYTICA Biotech Forum
Alexander Lazarev, Ph.D. presentation at ANALYTICA Biotech Forum
Company Spotlight
 
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciencesProtein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
Chris Suh
 
Lecture 3 biofactories in the biotechnology industry – introduction(2)
Lecture 3 biofactories in the biotechnology industry – introduction(2)Lecture 3 biofactories in the biotechnology industry – introduction(2)
Lecture 3 biofactories in the biotechnology industry – introduction(2)
Dr. Tan Boon Siong
 
PREPERATION F CELL EXTRACT
PREPERATION F CELL EXTRACTPREPERATION F CELL EXTRACT
PREPERATION F CELL EXTRACT
Yashwanth B S
 
UCARE report
UCARE reportUCARE report
UCARE report
Bree Drda
 
Ppt mikroum fixed
Ppt mikroum fixed Ppt mikroum fixed
Ppt mikroum fixed
Brawijaya University
 

What's hot (18)

Ricerca Early Safety Assays
Ricerca Early Safety AssaysRicerca Early Safety Assays
Ricerca Early Safety Assays
 
Sigma Xi - EKS95460- ekta sharma
Sigma Xi - EKS95460- ekta sharmaSigma Xi - EKS95460- ekta sharma
Sigma Xi - EKS95460- ekta sharma
 
Expression of Genetically Engineered Chitinase Gene of Pyrococcus furiosus
Expression of Genetically Engineered Chitinase Gene of Pyrococcus furiosusExpression of Genetically Engineered Chitinase Gene of Pyrococcus furiosus
Expression of Genetically Engineered Chitinase Gene of Pyrococcus furiosus
 
Overcoming Key Challenges of Protein Mass Spectrometry Sample Preparation
Overcoming Key Challenges of Protein Mass Spectrometry Sample PreparationOvercoming Key Challenges of Protein Mass Spectrometry Sample Preparation
Overcoming Key Challenges of Protein Mass Spectrometry Sample Preparation
 
Glass bead transformation method for gram positive bacteria
Glass bead transformation method for gram positive bacteriaGlass bead transformation method for gram positive bacteria
Glass bead transformation method for gram positive bacteria
 
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
Biocatalytic properties of a recombinant aldo keto reductase with broad subst...
 
Bio outsource vaccinetesting_europe
Bio outsource vaccinetesting_europeBio outsource vaccinetesting_europe
Bio outsource vaccinetesting_europe
 
J. Ingram, D. Poulcharidis - Adv. Topics of Chem. Bio. - Dr. Webb - Prof. S. ...
J. Ingram, D. Poulcharidis - Adv. Topics of Chem. Bio. - Dr. Webb - Prof. S. ...J. Ingram, D. Poulcharidis - Adv. Topics of Chem. Bio. - Dr. Webb - Prof. S. ...
J. Ingram, D. Poulcharidis - Adv. Topics of Chem. Bio. - Dr. Webb - Prof. S. ...
 
Take part in research to combat atherosclerosis
Take part in research to combat atherosclerosisTake part in research to combat atherosclerosis
Take part in research to combat atherosclerosis
 
Monoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionMonoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartion
 
Pepsi bio link
Pepsi bio linkPepsi bio link
Pepsi bio link
 
Bmm microbial enzymes
Bmm microbial enzymesBmm microbial enzymes
Bmm microbial enzymes
 
Alexander Lazarev, Ph.D. presentation at ANALYTICA Biotech Forum
Alexander Lazarev, Ph.D.  presentation at ANALYTICA Biotech ForumAlexander Lazarev, Ph.D.  presentation at ANALYTICA Biotech Forum
Alexander Lazarev, Ph.D. presentation at ANALYTICA Biotech Forum
 
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciencesProtein Purification and Analysis with PhyNexus and Caliper LifeSciences
Protein Purification and Analysis with PhyNexus and Caliper LifeSciences
 
Lecture 3 biofactories in the biotechnology industry – introduction(2)
Lecture 3 biofactories in the biotechnology industry – introduction(2)Lecture 3 biofactories in the biotechnology industry – introduction(2)
Lecture 3 biofactories in the biotechnology industry – introduction(2)
 
PREPERATION F CELL EXTRACT
PREPERATION F CELL EXTRACTPREPERATION F CELL EXTRACT
PREPERATION F CELL EXTRACT
 
UCARE report
UCARE reportUCARE report
UCARE report
 
Ppt mikroum fixed
Ppt mikroum fixed Ppt mikroum fixed
Ppt mikroum fixed
 

Similar to Blirt company overview

Nutrichip
NutrichipNutrichip
Nutrichip
dalgetty
 
Vijay protiomics current
Vijay protiomics currentVijay protiomics current
Vijay protiomics current
Rohit Bisht
 
LanglaisC_2007_Systematic approach to protein experssion in cell free systems
LanglaisC_2007_Systematic approach to protein experssion in cell free systemsLanglaisC_2007_Systematic approach to protein experssion in cell free systems
LanglaisC_2007_Systematic approach to protein experssion in cell free systems
Claudia Langlais
 
Eukayotic expression - vimmi.
Eukayotic expression - vimmi.Eukayotic expression - vimmi.
Eukayotic expression - vimmi.
Vimlesh Gupta
 
Refolding of inclusion body proteins from e. coli
Refolding of inclusion body proteins from e. coliRefolding of inclusion body proteins from e. coli
Refolding of inclusion body proteins from e. coli
Creative BioMart
 
Kariuki group nanobody expression artical
Kariuki group nanobody expression articalKariuki group nanobody expression artical
Kariuki group nanobody expression artical
Samuel Kariuki
 
Protein Chromatography
Protein ChromatographyProtein Chromatography
Protein Chromatography
Nicole Gomez
 
A Study On Bacterial Transformation
A Study On Bacterial TransformationA Study On Bacterial Transformation
A Study On Bacterial Transformation
Jessica Myers
 
Plasmid Lab Report
Plasmid Lab ReportPlasmid Lab Report
Plasmid Lab Report
Tammy Moncrief
 
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
Qing Chen
 
DNA Vaccine + Nanoparticles
DNA Vaccine + NanoparticlesDNA Vaccine + Nanoparticles
DNA Vaccine + Nanoparticles
Hamid Salari
 
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
InsideScientific
 
Recombinant protein through fermentation technology
Recombinant protein through fermentation technologyRecombinant protein through fermentation technology
Recombinant protein through fermentation technology
Dr. Ashish Warghane, Ph.D
 
Purification of protein involved in Mycobacterium tuberculosis as a potential...
Purification of protein involved in Mycobacterium tuberculosis as a potential...Purification of protein involved in Mycobacterium tuberculosis as a potential...
Purification of protein involved in Mycobacterium tuberculosis as a potential...
AmitSingh65788
 
26 ch05cellsoverview2007
26 ch05cellsoverview200726 ch05cellsoverview2007
26 ch05cellsoverview2007
sbarkanic
 
Ex Bio 2016 poster
Ex Bio 2016 posterEx Bio 2016 poster
Ex Bio 2016 poster
Shari Garrett
 
Biotechnological pharmaceuticals
Biotechnological pharmaceuticalsBiotechnological pharmaceuticals
Biotechnological pharmaceuticals
Gaurav Kr
 
Strategies for Recombinant protein production in E.coli
Strategies for Recombinant protein production in E.coliStrategies for Recombinant protein production in E.coli
Strategies for Recombinant protein production in E.coli
Uka Tarsadia University
 
Detection of the Antibacterial Activity of Bioactive Peptide Isolated from Fe...
Detection of the Antibacterial Activity of Bioactive Peptide Isolated from Fe...Detection of the Antibacterial Activity of Bioactive Peptide Isolated from Fe...
Detection of the Antibacterial Activity of Bioactive Peptide Isolated from Fe...
iosrjce
 
MC 313 PPT Lecture 3 (1).pptx
MC 313 PPT Lecture 3 (1).pptxMC 313 PPT Lecture 3 (1).pptx
MC 313 PPT Lecture 3 (1).pptx
DUSABEAngelique1
 

Similar to Blirt company overview (20)

Nutrichip
NutrichipNutrichip
Nutrichip
 
Vijay protiomics current
Vijay protiomics currentVijay protiomics current
Vijay protiomics current
 
LanglaisC_2007_Systematic approach to protein experssion in cell free systems
LanglaisC_2007_Systematic approach to protein experssion in cell free systemsLanglaisC_2007_Systematic approach to protein experssion in cell free systems
LanglaisC_2007_Systematic approach to protein experssion in cell free systems
 
Eukayotic expression - vimmi.
Eukayotic expression - vimmi.Eukayotic expression - vimmi.
Eukayotic expression - vimmi.
 
Refolding of inclusion body proteins from e. coli
Refolding of inclusion body proteins from e. coliRefolding of inclusion body proteins from e. coli
Refolding of inclusion body proteins from e. coli
 
Kariuki group nanobody expression artical
Kariuki group nanobody expression articalKariuki group nanobody expression artical
Kariuki group nanobody expression artical
 
Protein Chromatography
Protein ChromatographyProtein Chromatography
Protein Chromatography
 
A Study On Bacterial Transformation
A Study On Bacterial TransformationA Study On Bacterial Transformation
A Study On Bacterial Transformation
 
Plasmid Lab Report
Plasmid Lab ReportPlasmid Lab Report
Plasmid Lab Report
 
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
A visual chip-based coimmunoprecipitation technique for analysis of protein–p...
 
DNA Vaccine + Nanoparticles
DNA Vaccine + NanoparticlesDNA Vaccine + Nanoparticles
DNA Vaccine + Nanoparticles
 
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
Recombinant Antibody Production: Current Methods and a Novel Antibody Generat...
 
Recombinant protein through fermentation technology
Recombinant protein through fermentation technologyRecombinant protein through fermentation technology
Recombinant protein through fermentation technology
 
Purification of protein involved in Mycobacterium tuberculosis as a potential...
Purification of protein involved in Mycobacterium tuberculosis as a potential...Purification of protein involved in Mycobacterium tuberculosis as a potential...
Purification of protein involved in Mycobacterium tuberculosis as a potential...
 
26 ch05cellsoverview2007
26 ch05cellsoverview200726 ch05cellsoverview2007
26 ch05cellsoverview2007
 
Ex Bio 2016 poster
Ex Bio 2016 posterEx Bio 2016 poster
Ex Bio 2016 poster
 
Biotechnological pharmaceuticals
Biotechnological pharmaceuticalsBiotechnological pharmaceuticals
Biotechnological pharmaceuticals
 
Strategies for Recombinant protein production in E.coli
Strategies for Recombinant protein production in E.coliStrategies for Recombinant protein production in E.coli
Strategies for Recombinant protein production in E.coli
 
Detection of the Antibacterial Activity of Bioactive Peptide Isolated from Fe...
Detection of the Antibacterial Activity of Bioactive Peptide Isolated from Fe...Detection of the Antibacterial Activity of Bioactive Peptide Isolated from Fe...
Detection of the Antibacterial Activity of Bioactive Peptide Isolated from Fe...
 
MC 313 PPT Lecture 3 (1).pptx
MC 313 PPT Lecture 3 (1).pptxMC 313 PPT Lecture 3 (1).pptx
MC 313 PPT Lecture 3 (1).pptx
 

Recently uploaded

Artificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopmentArtificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopment
Octavian Nadolu
 
20240605 QFM017 Machine Intelligence Reading List May 2024
20240605 QFM017 Machine Intelligence Reading List May 202420240605 QFM017 Machine Intelligence Reading List May 2024
20240605 QFM017 Machine Intelligence Reading List May 2024
Matthew Sinclair
 
GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024
GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024
GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024
Neo4j
 
Presentation of the OECD Artificial Intelligence Review of Germany
Presentation of the OECD Artificial Intelligence Review of GermanyPresentation of the OECD Artificial Intelligence Review of Germany
Presentation of the OECD Artificial Intelligence Review of Germany
innovationoecd
 
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024
GraphSummit Singapore | The Art of the  Possible with Graph - Q2 2024GraphSummit Singapore | The Art of the  Possible with Graph - Q2 2024
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024
Neo4j
 
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
名前 です男
 
HCL Notes and Domino License Cost Reduction in the World of DLAU
HCL Notes and Domino License Cost Reduction in the World of DLAUHCL Notes and Domino License Cost Reduction in the World of DLAU
HCL Notes and Domino License Cost Reduction in the World of DLAU
panagenda
 
Pushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 daysPushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 days
Adtran
 
Video Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the FutureVideo Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the Future
Alpen-Adria-Universität
 
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with SlackLet's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
shyamraj55
 
TrustArc Webinar - 2024 Global Privacy Survey
TrustArc Webinar - 2024 Global Privacy SurveyTrustArc Webinar - 2024 Global Privacy Survey
TrustArc Webinar - 2024 Global Privacy Survey
TrustArc
 
Mind map of terminologies used in context of Generative AI
Mind map of terminologies used in context of Generative AIMind map of terminologies used in context of Generative AI
Mind map of terminologies used in context of Generative AI
Kumud Singh
 
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
Neo4j
 
RESUME BUILDER APPLICATION Project for students
RESUME BUILDER APPLICATION Project for studentsRESUME BUILDER APPLICATION Project for students
RESUME BUILDER APPLICATION Project for students
KAMESHS29
 
Microsoft - Power Platform_G.Aspiotis.pdf
Microsoft - Power Platform_G.Aspiotis.pdfMicrosoft - Power Platform_G.Aspiotis.pdf
Microsoft - Power Platform_G.Aspiotis.pdf
Uni Systems S.M.S.A.
 
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...
Edge AI and Vision Alliance
 
Building Production Ready Search Pipelines with Spark and Milvus
Building Production Ready Search Pipelines with Spark and MilvusBuilding Production Ready Search Pipelines with Spark and Milvus
Building Production Ready Search Pipelines with Spark and Milvus
Zilliz
 
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfObservability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Paige Cruz
 
UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6
DianaGray10
 
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdfUnlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Malak Abu Hammad
 

Recently uploaded (20)

Artificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopmentArtificial Intelligence for XMLDevelopment
Artificial Intelligence for XMLDevelopment
 
20240605 QFM017 Machine Intelligence Reading List May 2024
20240605 QFM017 Machine Intelligence Reading List May 202420240605 QFM017 Machine Intelligence Reading List May 2024
20240605 QFM017 Machine Intelligence Reading List May 2024
 
GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024
GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024
GraphSummit Singapore | Neo4j Product Vision & Roadmap - Q2 2024
 
Presentation of the OECD Artificial Intelligence Review of Germany
Presentation of the OECD Artificial Intelligence Review of GermanyPresentation of the OECD Artificial Intelligence Review of Germany
Presentation of the OECD Artificial Intelligence Review of Germany
 
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024
GraphSummit Singapore | The Art of the  Possible with Graph - Q2 2024GraphSummit Singapore | The Art of the  Possible with Graph - Q2 2024
GraphSummit Singapore | The Art of the Possible with Graph - Q2 2024
 
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
みなさんこんにちはこれ何文字まで入るの?40文字以下不可とか本当に意味わからないけどこれ限界文字数書いてないからマジでやばい文字数いけるんじゃないの?えこ...
 
HCL Notes and Domino License Cost Reduction in the World of DLAU
HCL Notes and Domino License Cost Reduction in the World of DLAUHCL Notes and Domino License Cost Reduction in the World of DLAU
HCL Notes and Domino License Cost Reduction in the World of DLAU
 
Pushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 daysPushing the limits of ePRTC: 100ns holdover for 100 days
Pushing the limits of ePRTC: 100ns holdover for 100 days
 
Video Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the FutureVideo Streaming: Then, Now, and in the Future
Video Streaming: Then, Now, and in the Future
 
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with SlackLet's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
Let's Integrate MuleSoft RPA, COMPOSER, APM with AWS IDP along with Slack
 
TrustArc Webinar - 2024 Global Privacy Survey
TrustArc Webinar - 2024 Global Privacy SurveyTrustArc Webinar - 2024 Global Privacy Survey
TrustArc Webinar - 2024 Global Privacy Survey
 
Mind map of terminologies used in context of Generative AI
Mind map of terminologies used in context of Generative AIMind map of terminologies used in context of Generative AI
Mind map of terminologies used in context of Generative AI
 
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
GraphSummit Singapore | Graphing Success: Revolutionising Organisational Stru...
 
RESUME BUILDER APPLICATION Project for students
RESUME BUILDER APPLICATION Project for studentsRESUME BUILDER APPLICATION Project for students
RESUME BUILDER APPLICATION Project for students
 
Microsoft - Power Platform_G.Aspiotis.pdf
Microsoft - Power Platform_G.Aspiotis.pdfMicrosoft - Power Platform_G.Aspiotis.pdf
Microsoft - Power Platform_G.Aspiotis.pdf
 
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...
“Building and Scaling AI Applications with the Nx AI Manager,” a Presentation...
 
Building Production Ready Search Pipelines with Spark and Milvus
Building Production Ready Search Pipelines with Spark and MilvusBuilding Production Ready Search Pipelines with Spark and Milvus
Building Production Ready Search Pipelines with Spark and Milvus
 
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdfObservability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
Observability Concepts EVERY Developer Should Know -- DeveloperWeek Europe.pdf
 
UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6UiPath Test Automation using UiPath Test Suite series, part 6
UiPath Test Automation using UiPath Test Suite series, part 6
 
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdfUnlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
Unlock the Future of Search with MongoDB Atlas_ Vector Search Unleashed.pdf
 

Blirt company overview

  • 1. A flexible, affordable and fast R&D outsourcing service partner
  • 2. Company overview BLIRT (BioLab Innovative Research Technologies) is a private biotechnology company founded in 2008 with head office based in Gdansk, Poland. BLIRT has a unique hybrid model, an innovative biopharmaceutical service provider with Contract Research Organization. BLIRT offers a suite of biology and chemistry services, attractive especially for discovery and lead optimization development phase.  BLIRT has modern laboratories and competent staff with a high percentage of internationally educated PhDs. We are able to accommodate small and bigger projects, and can engage project resources on long term contract or as-needed basis. www.blirt.eu 2
  • 3. Research Team  891 publications in the field of life science ( Medicine, Microbiology, Molecular Biology, Biotechnology, Biochemistry, Organic Chemistry, Analytical Chemistry, Molecular Modeling) BLIRT employes 34 people after 2 years activity. The Research Team consists of 22 researchers where 9 are PhDs at molecular biology, biotechnology, organic chemistry and computer chemistry. www.blirt.eu 3
  • 4. Our machinery www.blirt.eu 4
  • 5. Protein Department We offer a broad spectrum of custom services from gene to protein helping you to speed up your development and to increase the efficiency. Gene Production Purification Protein In silico gene synthesis Proof of concept Downstream Processing Formulation Adjustment Metagenomics Difficult to express Optimization proteins solutions Analytical testing PCR Chromatography methods E.coli, P.pastoris, development and validation DNA and cDNA library B. megaterium, S.cerevisiae construction Unique resin synthesis Flask and Bioreactor (10L) for special proteins Gene engineering expression optimizations www.blirt.eu
  • 6. Protein Department Choosing the right expression strain of E.coli Expression T7 system: OD600=0,3, IPTG to 1 2 3 4 5 6 M 7 8 9 10 11 12 1mM, 30oC, 6h, TB broth. 1. E.coli strain 1 protein I (whole fraction) 2. E.coli strain 1 protein I (soluble fraction) 3. E.coli strain 2 protein I (whole fraction) 4. E.coli strain 2 protein I (soluble fraction) 5. E.coli strain 3 protein I (whole fraction) 6. E.coli strain 3 protein I (soluble fraction) M. Protein weight marker (170, 130, 100, 70, 55, 40, 35, 25, 15, 10 kDa) 7. E.coli strain 4 protein I (whole fraction) 8. E.coli strain 4 protein I (soluble fraction) 9. E.coli strain 5 protein I (whole fraction) 10. E.coli strain 5 protein I (soluble fraction) 11. E.coli strain 6 protein I (whole fraction) 12. E.coli strain 6 protein I (soluble fraction) www.blirt.eu 6
  • 7. Protein Department Screening for expression temperature Purification M 1 2 3 4 M 1 2 3 4 5 5 6 Expression T7 system: OD600=0,3, IPTG to 1mM, various oC, 6 h, TB broth. Expression T7 system: OD600=0,3, IPTG to 1mM, 37 oC, 6 h, TB broth. M. Protein weight marker (170, 130, 100, 70, 55, 40, 35, 25, 15, 10 kDa) M. Protein weight marker (130, 90, 66, 40, 25, 10 kDa) 1. 18oC E.coli strain 1 protein II (whole fraction) 1. E.coli strain 2 protein III (soluble fraction) 2. 18oC E.coli strain 1 protein II (soluble fraction) 2. E.coli strain 2 protein III DEAE Sepharose week anion exchanger 3. 30oC E.coli strain 1 protein II (whole fraction) 3. E.coli strain 2 protein III Mono Q strong anion exchanger 4. 30oC E.coli strain 1 protein II (soluble fraction) 4. E.coli strain 2 protein III Octyl Sepharose HIC 5. 37oC E.coli strain 1 protein II (whole fraction) 5. Formulated protein III 6. 37oC E.coli strain 1 protein II (soluble fraction) www.blirt.eu 7
  • 8. Protein Department 1 2 M 4 5 6 7 8 9 10 11 12 13 14 15 Intracellular production of a therapeutic protein by E.coli. Soluble protein Loading buffer at various pH. Elution stepwise with 50mM Hepes 1M NaCl pH=7,0 DEAE Sepharose 1. pH=4,5 2. pH=5,5 M. Protein weight marker (170, 130, 100, 70, 55, 40, 35, 25, 15, 10 kDa) 4. pH=6,5 Loading buffer containing Triton X- 5. pH=7,5 100 (R) as additive at various pH. 6. pH=8,5 Elution stepwise with 50mM Hepes 7. pH=9,5 1M NaCl pH=7,0 8. pH=10,5 CM Sepharose 9. pH=4,5 10. pH=5,5 11. pH=6,5 Loading buffer containing L- 12. pH=7,5 Arginine as additive at various pH. 13. pH=8,5 Elution stepwise with 50mM Hepes 14. pH=9,5 1M NaCl pH=7,0 15. pH=10,5 www.blirt.eu 8
  • 9. Analysis department BLIRT specializes in development of new methods and analyses that are not possible in diagnostics laboratories. We are also able to conduct all routine tests, particularly those that require our unique equipment. Example analyses that we are able to perform: • Analysis of drugs and its metabolites concentration in blood, urine, other biological fluids and tissues, • Pharmacokinetic analysis after drug administration, • ADME studies – complex analysis of absorption, distribution, metabolism and excretion, • Analysis of purity, stability and protein binding of pharmaceuticals, • Analysis of biochemical markers in blood, urine, other biological fluids and tissues, • Determination of molecular weight and purity of proteins and peptides, • Protein and peptide sequencing following partial proteolysis. www.blirt.eu 9
  • 10. Analysis department BLIRT can provide you access to most advanced analytical equipment and high profile scientists with many years of experience in biomedical analytics. Overview of Analytical Methods: Ultra-High Performance Lipid Chromatography with mass detection (UHPLC-MS/MS) connected to newest generation of quadrupole time of flight mass detector (Q-TOF) with source of ions type electro-spray (ESI) or chemical ionization under atmospheric pressure (APCI). High Performance Lipid Chromatography (HPLC) with detection: RID, FL and UV-DAD. Infrared spectroscopy with Fourier Transformation (IR). Spectroscopy UV-VIS. Detectors: Overview of Analytical Equipment: micrOTOF-Q-II - Bruker Spectrometer UV-VIS – Jasco RID – Shodex Spectrometer IR- Jasco FL-Merck HPLC-Merck UV-DAD - Dionex UHPLC-Dionex FID- Perkin Elmer PLC- Dionex ECD-Perkin Elmer GC-Perkin- Elmer NPD- Perkin Elmer MS/MS - Bruker 10
  • 11. Synthesis department BLIRT – Synthesis services We offer all-embracing organic synthesis services directed to industrial and scientific customers:  Pharmaceutical Industry;  Chemical Industry;  Academic Scientists; In particular we specialize in synthesis:  chiral compounds with natural origin – with synthetic and bio-catalytic methods;  chiral unnatural/non-peptidic amino acids;  peptides (‘on solid state’ and ‘in solution’);  heterocyclic compounds (with N, O, S in ring structure);  macrocyclic compounds;  phosphoroorganic compounds; www.blirt.eu 11
  • 12. Synthesis department We offer comprehensive organic synthesis and interdisciplinary chemistry services:  Custom synthesis - comprehensive equiped laboratory: mg – 100s g scale;  Design of alternative synthetic pathways;  Optimalization of synthetic routes;  Reaction yields optimalization;  Identification, synthesis and standarization of API impurities;  Identification, synthesis and standarization of drug metabolites; COOMe O OH CHO A B CH3 CH3 Br COOMe COOMe F CH3 F F C OH CH3 E D CH3 CH3 O CN COOH O COOH F www.blirt.eu
  • 13. Collaboration models  Fee for Service  Co-development  FTE  Consulting www.blirt.eu 13
  • 14. Summary Key benefits of collaboration • Competitive pricing • Short project deadlines • Strong scientific team • State of the art facilities  Service Quality • ISO 9001:2009 - certificate • GLP - pending.- 03.2011 • GMP – planned for 2013 14